Welcome to the InfoSci Platform
Pharmaceuticals in Environment: Global Concerns and Regulations

Pharmaceuticals in Environment: Global Concerns and Regulations

Alka Bali
Copyright: © 2022 |Pages: 27
ISBN13: 9781668437148|ISBN10: 1668437147|EISBN13: 9781668437155
DOI: 10.4018/978-1-6684-3714-8.ch016
Cite Chapter Cite Chapter

MLA

Bali, Alka. "Pharmaceuticals in Environment: Global Concerns and Regulations." Research Anthology on Emerging Techniques in Environmental Remediation, edited by Information Resources Management Association, IGI Global, 2022, pp. 308-334. https://doi.org/10.4018/978-1-6684-3714-8.ch016

APA

Bali, A. (2022). Pharmaceuticals in Environment: Global Concerns and Regulations. In I. Management Association (Ed.), Research Anthology on Emerging Techniques in Environmental Remediation (pp. 308-334). IGI Global. https://doi.org/10.4018/978-1-6684-3714-8.ch016

Chicago

Bali, Alka. "Pharmaceuticals in Environment: Global Concerns and Regulations." In Research Anthology on Emerging Techniques in Environmental Remediation, edited by Information Resources Management Association, 308-334. Hershey, PA: IGI Global, 2022. https://doi.org/10.4018/978-1-6684-3714-8.ch016

Export Reference

Mendeley
Favorite

Abstract

Pharmaceuticals and personal care products (PPCPs) constitute an integral part of modern healthcare systems which enter the environment through various routes. Because of their inherent biological activity, their presence in soil and the aquatic environment poses several eco-toxicological problems. Antibiotic contamination of soil and water bodies is leading to the development of microbial resistance to antibiotics and this has been recognized by several global bodies like WHO and EPA. Effective steps need to be taken in this regard including increased awareness, reduced pharmaceutical discharges in environment, green and sustainable pharmaceutical practice by pharmaceutical industry and healthcare professionals and improved remediation/bioremediation methods. This chapter outlines the various anticipated routes of exposure of pharmaceuticals to the environment along with their detrimental effects, fate and degradation in aquatic and terrestrial environments. The chapter also dwells upon the role of various regulatory bodies and plausible measures that may be adopted to alleviate the problem.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.